0.00Open0.15Pre Close0 Volume5 Open Interest3.00Strike Price0.00Turnover307.65%IV118.75%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.2982Delta0.3046Gamma9.60Leverage Ratio-0.0082Theta0.0002Rho2.86Eff Leverage0.0013Vega
Vivani Medical Stock Discussion
Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
NPM-115 clinical program utilizes a miniature, GLP-1 (exenatide) implant designed to provide comparable efficacy to semaglutide, the active ingredient in Ozempic®/Wegovy®, with twice-yearly administration
Study will represent the first clinical application of NanoPortal™, the Company's proprietary drug implant pla...
EXCLUSIVE: Vivani Medical Tells Benzinga 'Felines Share Many Pathophysiologic Obesity Phenotypes With Humans, Further Supporting Clinical Evaluations of Miniature, Subdermal GLP-1 Implants for Obesity Reduction'
$Vivani Medical (VANI.US)$
📊⚡️📊
No comment yet